
Commercial success in precision medicine diagnostics: Watchouts and best practices
Published on August 19, 2025
Precision medicine is transforming the pharmaceutical landscape, delivering highly targeted therapies that drive significant improvements in patient outcomes. However, without a robust companion diagnostics (CDx) strategy, even the most innovative treatments risk falling short of their commercial and clinical potential.
Join our upcoming webinar to explore the critical steps for driving biomarker testing adoption, from building physician awareness to enabling informed treatment decisions. Drawing on real-world examples and industry benchmarks, we will identify common bottlenecks, explain why they matter, and share practical solutions to address them proactively.
This webinar will cover:
